Chairman
Faeth Therapeutics, Inc. (FTH)Board Member
Faeth Therapeutics, Inc. (FTH)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Anand Parikh is recorded as COO, CEO, Chairman and Board Member at Faeth Therapeutics, Inc. (FTH). Faeth Therapeutics, Inc. reported in an 8-K filed June 15, 2026 that Anand Parikh was appointed Chair of the Board, effective June 12, 2026. Faeth Therapeutics, Inc. reported in an 8-K filed June 15, 2026 that Anand Parikh was appointed President and Chief Executive Officer, effective June 13, 2026. Faeth Therapeutics, Inc. reported in an 8-K filed February 18, 2026 that Anand Parikh was appointed Chief Operating Officer of the Company, effective February 17, 2026. Equibles holds 4 filed executive changes naming Anand Parikh; each is listed under recent activity with its source filing. Anand Parikh has spoken on 2 investor events across 1 company, most recently for Faeth Therapeutics, Inc. on September 16, 2026.
“Also effective as of June 12, 2026, the Board decreased its size from six to five members and appointed Mr. Parikh as the chair of the Board.”
“The Board of Directors (the “Board”) of the Company appointed Anand Parikh as President and Chief Executive Officer of the Company, effective as of June 13, 2026 (the “Effective Date”).”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2026-06-13–present
2026-06-12–present
2026-02-17–present
Start not stated–present
Recorded roles and call appearances connecting this person to public companies.
COO, CEO, Chairman, Board Member
2026-02-17–present
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
